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Atherosclerosis is an inflammatory disease in which an accumulation of fatty 
acids and cholesterol occurs to form a plaque in small and large arteries. Monocyte 
polarization to classic M1 macrophages or alternative M2 macrophages is an important 
area of research that can determine the severity of disease progression. BMP-7 is a key 
growth factor responsible for directing differentiation of mesenchymal stem cells into 
brown fat cells, suggesting a role of BMP-7 in cellular plasticity; however, its role in 
monocyte polarization is yet to be revealed. In the current study, we hypothesize that 
monocyte treatment with BMP-7 will significantly result in increased polarization of 
monocytes into M2 macrophages and increased expression of anti-inflammatory 
cytokines. To that effect, we have established a stress induced cell culture system with 
monocytes (THP-1 cells) and apoptotic conditioned medium (ACM), simulating injury, to 
understand the effects of BMP-7 on M2 macrophage polarization from monocytes. Our 
data demonstrates that the BMP type 2 receptor (BMPR2) is found on monocytes and 
its activation is significantly (p<0.05) increased in both monocytes and M2 macrophages 
following treatment with BMP-7. Furthermore, a significant (p<0.05) increase of M2 
macrophages in the BMP-7 treated group was shown following immunostaining with 
CD206 and arginase-1, two M2 macrophage markers, whereas a significant (p<0.05) 
decrease of iNOS expression, an M1 macrophage marker, was shown.  Moreover, 
treatment with BMP-7 resulted in significantly (p<0.05) increased expression of IL-10 
and IL-1ra, two anti-inflammatory cytokines, but significantly (p<0.05) decreased levels 
of the pro-inflammatory cytokines, MCP-1, IL-6 and TNF-α.  We also hypothesize that 
polarization of monocytes to M2 macrophages occurs through activation of SMAD1/5/8 
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and PI3K-Akt-mTOR pathways.  Upon BMP-7 binding to its receptor, BMPR2, activation 
of SMAD1/5/8 occurs which then activates the p85 subunit of PI3K resulting in 
downstream activation of Akt and mTOR.  Our data shows that following treatment with 
BMP-7, expression of p-SMAD1/5/8, p-PI3K, p-Akt and p-mTOR is significantly (p<0.05) 
increased compared to controls whereas p-PTEN, an inhibitor of the PI3K pathway, is 
significantly (p<0.05) decreased in the BMP-7 treated group compared to controls.  In 
conclusion, our data reveals that BMP-7 polarizes monocytes into M2 macrophages and 
it achieves this through activation of the PI3K-Akt-mTOR pathway, which will have 
significant applications for atherosclerosis treatment.  
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CHAPTER 1: INTRODUCTION 
Atherosclerosis and Inflammation  
Atherosclerosis is a disease which results in the accumulation of fat and 
cholesterol in large and small arteries (Seimon and Tabas, 2009;Moore and Tabas, 
2011;Shimizu et al., 2012).  This plaque formation that occurs causes hardening and 
narrowing of the arteries which can lead to further complications such as a myocardial 
infarction or an ischemic stroke (Libby et al., 2009;Rocher et al., 2012).  Recently 
studies have focused on the inflammatory response that occurs with atherosclerosis 
and refer to this condition as an inflammatory disease (Libby et al., 2009).  In 
atherosclerosis, monocytes migrate to the area of injury and polarize based on the 
environment and the factors being secreted (Seimon and Tabas, 2009).  In early stages 
of atherosclerosis, polarization of M2 macrophages is greater and allows for secretion of 
anti-inflammatory cytokines and efferocytosis to occur but in later stages of 
atherosclerosis, the injury becomes too great and cellular debris becomes necrotic 
causing a pro-inflammatory environment and M1 polarization from monocytes to occur 
(Thorp and Tabas, 2009;Libby et al., 2009;Seimon and Tabas, 2009;Moore and Tabas, 
2011).  
Monocyte Polarization 
Monocyte polarization involving classical M1 macrophages and alternative M2 
macrophages is an emerging area of research that plays a significant role in various 
conditions and diseases (Xu et al., 2006;Weis et al., 2009;Rocher et al., 2012). 
Classical M1 macrophages are known to be pro-inflammatory and secrete such 
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cytokines as iNOS, IL-6, TNF-α, and MCP-1, while alternative M2 macrophages are 
anti-inflammatory and secrete such cytokines as IL-10 and arginase-1 (Sinha et al., 
2005;Xu et al., 2006;Weis et al., 2009;Rocher et al., 2012).  Therefore, having a greater 
ratio of M2 macrophages is essential for injury repair and wound healing.  Monocyte 
polarization is also influenced by the stimuli received from the external environment 
based on their ability to exhibit high plasticity (Woollard and Geissmann, 2010;Rocher et 
al., 2012).  
Bone Morphogenetic Protein-7 and SMAD1/5/8 Pathway 
Bone morphogenetic protein-7 (BMP-7), which is part of the TGFβ family, is 
essential for the embryonic development of the eyes, kidneys and skeleton, is shown to 
be involved in cell polarization and demonstrated to reduce expression of such pro-
inflammatory cytokines as IL-6 and MCP-1 in the kidney (Wang et al., 2003;Boon et al., 
2011;Rocher et al., 2012).  Furthermore, we recently published the effect of BMP-7 
treatment on THP-1 cells as well as the effects of its inhibitor, follistatin (Rocher et al., 
2012).  We showed that BMP-7 treatment was able to successfully increase anti-
inflammatory cytokine expression such as IL-10 and induce increased polarization of 
monocytes to M2 macrophages (Rocher et al., 2012). BMP-7 works through the 
SMAD1/5/8 pathway following binding to the BMP type 2 receptor (BMPR2) on the 
surface of the cell (Boon et al., 2011).  Follistatin works to inhibit BMP-7 by preventing 
the binding of BMP-7 with BMPR2 and thus preventing the activation of the SMAD1/5/8 
pathway (Amthor et al., 2002;Rocher et al., 2012).  Binding of BMP-7 with its receptor, 
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however, has also been shown to activate other non-SMAD pathways such as the PI3K-
Akt-mTor pathway (Shimizu et al., 2012).   
PI3K-Akt-mTOR Pathway 
 The PI3K pathway has been shown to be essential to immune regulation and 
induces a more anti-inflammatory environment (Weichhart and Saemann, 2008).  
Studies have reported that this pathway inhibits the release of pro-inflammatory 
cytokines and its activation is required for M2 macrophage polarization (Rauh et al., 
2005;Weichhart and Saemann, 2008;Weichhart and Saemann, 2009).  This pathway, 
works through the activation and phosphorylation of the p85 subunit of PI3K which 
results in downstream phosphorylation of PIP2 to PIP3 (Weichhart and Saemann, 
2008).  This results in phosphorylation of Akt and downstream activation of mTOR 
(Weichhart and Saemann, 2008).  PTEN, an inhibitor of this pathway, works by 
dephosphorylating PIP3 and thus preventing activation of Akt (Weichhart and Saemann, 
2008).  In this study we will show that following treatment of BMP-7, THP-1 cells will 
polarize into M2 macrophages.  Furthermore, we will show that activation of the 
SMAD1/5/8 pathway will activate the p85 subunit of PI3K resulting in activation of the 
PI3K-Akt-mTOR pathway.   
Hypothesis  
In the present study, we hypothesize that: 
I. Monocyte treatment with BMP-7 under stressed conditions will greatly increase 
polarization of monocytes into M2 macrophages and increase expression of anti-
inflammatory cytokines.   
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II. Polarization by BMP-7 is mediated through both the SMAD1/5/8 and PI3K-Akt-
mTOR pathways.  
Aims 
 Aim 1. Determine whether under stressed conditions, BMP-7 can induce M2 
macrophage polarization from THP-1 cells and primary CD14 monocytes after 48 hours 
of treatment. 




CHAPTER 2: MATERIALS AND METHODS 
THP-1 Cell Culture 
THP-1 cells are a cell line for human monocytes that were used in this study and 
purchased from ATCC.  The monocytes were cultured with RPMI 1640 (ATCC) which 
contained 10% fetal bovine serum and 0.05mM β-mercaptoethanol.  THP-1 cells were 
grown in suspension in 25cm2 flasks and media was added every other day as per 
manufacturer’s instructions (Rocher et al., 2012).  
Apoptotic Conditioned Media 
The H9C2 cell line was used to generate apoptotic condition media which is an 
established method and has been published by us (Singla and McDonald, 2007;Rocher 
et al., 2012).  A 60mm tissue culture plate was plated with 5x105 H9C2 cells for 24 
hours.  Following 24 hours, 400uM of H2O2 was added to the plate for 2 hours.  After 2 
hours, the media was removed from the plate and filtered. 
BMP-7 and Follistatin Treatment 
A total of 40,000 THP-1 cells were plated per well in a 24 well plate for 24 hours. 
The cells were split up into the following groups:  Control, ACM, ACM+BMP-7 and 
ACM+BMP-7+Foll.  Following 24 hours, cells were treated according to the designated 
groups for 48 hours.  Cells treated with BMP-7 were given a concentration of 660ng/ml 
and cells treated with follistatin were given a concentration of 500ng/ml (Rocher et al., 
2012). 
6 
Double Label Immunostaining of BMPR2 with CD14 and CD206 
As previously reported, after 48 hours of treatment, cells were removed from the 
wells and centrifuged for 5 minutes at 300g (Rocher et al., 2012).  Following 
centrifugation, cell smears were made using ColorFrost Plus glass slides and allowed to 
dry.  When smears were ready blocking was done with 10% normal goat serum (Vector 
Labs) for one hour at room temperature. Primary antibodies for anti-CD14 or anti-
CD206 were added and incubated for 24 hours. Smears were then left in secondary 
antibody goat anti-rabbit Alexa 568 for one hour. Next smears were blocked with 10% 
donkey serum and then primary antibody anti-BMPR2 was added for 24 hours.  
Secondary antibody donkey anti-goat Alexa 488 was then added.  Smears were then 
counter stained to visualize all blue nuclei with DAPI (4’, 6-diamidino-2-phenylindole) 
(Vector Labs) and the slides were cover-slipped.  Four images per smear were taken 
and analyzed. 
Immunohistochemistry of Macrophage Markers Arginase-1 and iNOS  
First, smears were blocked with 10% normal goat serum (Vector Labs). Next, 
anti-iNOS was added and kept for 24 hours.  Goat anti-mouse Alexa 568, the 
secondary, was then added. Next, smears were blocked with 10% donkey serum and 
then anti-arginase-1 was added also for 24 hours.  Smears were next given secondary 
antibody donkey anti-goat Alexa 488.  Smears were then counter stained to visualize all 
blue nuclei with DAPI (4’, 6-diamidino-2-phenylindole) (Vector Labs) and the slides were 
cover-slipped.  Four images per smear were taken and analyzed.   
7 
Pro and Anti-Inflammatory Cytokine ELISAs 
Supernatant from each group was collected after 48 hours of treatment and 
centrifuged at 13,000 rpm for 5 minutes as previously reported (Rocher et al., 2012).  In 
brief, pro (IL-6, TNF-α, and MCP-1) and anti-inflammatory (IL-10) ELISA kits were 
purchased from Raybiotech and followed under manufacturer’s instructions.  
Western Blot Analysis 
Cells were divided and plated in 25cm2 flasks per group.  Following 48 hours of 
treatment, cells were collected, centrifuged and lysed with RIPA buffer containing 
protease inhibitor cocktail, PMSF, sodium orthovanadate and sodium fluoride for 30 
minutes.  The cell lysates were then used to measure the protein concentration and 
following, protein concentration determination, samples were made from the cell lysates 
and were run on either an 8% or 10% sodium-dodecyl sulfate polyacrylamide gel at 
100V for 5 minutes and then 150V for 55 minutes.  Next the gels were transferred onto 
a PVDF membrane (Bio-Rad).  After transferring the gels onto the membrane, the 
membranes were blocked with 5% milk and primary antibodies p-Smad 1/5/8, p-PI3K, 
Total PI3K, p-Akt, p-PTEN, p-mTOR or Total mTOR were added followed by secondary 
antibody.  Finally the membranes were detected with a Visualizer. 
Statistical Analysis 
Statistical analysis was done using one-way analysis of variance (ANOVA) then 




CHAPTER 3: RESULTS 
BMPR2 Expression is Increased Following BMP-7 Treatment 
To confirm the presence of BMPR2 on THP-1 cells, a double immunostaining 
was performed.  Figure 1A shows representative photomicrographs of THP-1 cells 
stained with CD14, a monocyte marker, and BMPR2.  Furthermore, quantitative 
analysis shows that expression of BMPR2 is significantly increased in the ACM+BMP-7 
group following treatment with BMP-7 compared to control (Figure 1C).  A double 
immunostaining with CD206, an M2 macrophage marker, and BMPR2 further 
demonstrates that the receptor is located on M2 macrophages as well and expression 
of the receptor is significantly increased in the ACM+BMP-7 group following treatment 
with BMP-7 compared to the control (Figure 1B and D). 
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Figure 1:  Expression of BMPR2 is increased following treatment with BMP-7.  Top 
panel (A) shows representative photomicrographs of cell smears stained with anti-
BMPR2 in green (a), anti-CD14, a monocyte marker, in red (b), DAPI in blue (c) and the 
merged image (d).  Bottom panel (B) shows representative photomicrographs of anti-
BMPR2 in green (e), anti-CD206, an M2 macrophage marker, in red (f), DAPI in blue (g) 
and the merged image (h). Bottom left histogram (C) shows quantitative analysis of 
percent BMPR2 positive CD14 cells. Right histogram (D) shows quantitative analysis of 
percent BMPR2 positive CD206 cells. *p<0.05 vs Control. 
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BMP-7 Treatment Increases M2 Macrophage Polarization  
Polarization of THP-1 cells following treatment with BMP-7 was next determined 
by immunohistochemistry.  Figure 2A shows quantitative analysis of CD14 
immunostaining showing a significant decrease of CD14 positive cells in the ACM, 
ACM+BMP-7 and ACM+BMP-7+Foll groups.  This suggests that the cells are polarizing 
into another cell type following treatment.  To determine what the cells are polarizing 
into, THP-1 cells were stained with CD206 and arginase-1, two M2 macrophage marker, 
and iNOS, an M1 macrophage marker (Sinha et al., 2005;Xu et al., 2006;Weichhart and 
Saemann, 2008).  Figure 2B shows quantitative analysis of CD206 positive cells with a 
significant increase in the ACM+BMP-7 group and a significant decrease in the 
ACM+BMP-7+Follistatin group suggesting that BMP-7 treatment successfully polarizes 
THP-1 cells into M2 macrophages and follistatin, an inhibitor of BMP-7, prevents the 
polarization from occurring (Boon et al., 2011).  Next, Figure 2C shows quantitative 
analysis of arginase-1 positive cells with a significant increase in the ACM+BMP-7 
group which further suggests that BMP-7 is successfully polarizing the THP-1 cells into 
M2 macrophages.  Lastly, Figure 2D shows quantitative analysis of iNOS positive cells 
with a significant increase in the ACM and ACM+BMP-7+Foll groups and a significant 
decrease in the ACM+BMP-7 group.  This suggests that without treatment of BMP-7 








































































































































































































Figure 2:  Treatment with BMP-7 increases M2 macrophage markers while decreasing 
M1 markers.  Top left histogram (A) shows quantitative analysis of percent CD14 
positive cells.  Top right histogram (B) shows quantitative analysis of percent CD206 
positive cells.  Bottom left histogram (C) shows quantitative analysis of percent 
arginase-1 positive cells.  Bottom right histogram (D) shows quantitative analysis of 




Expression of Inflammatory Cytokines Following Treatment with BMP-7 
Another method of determining M1 and M2 macrophage polarization is by 
expression of pro and anti-inflammatory cytokines (El et al., 2012;Rocher et al., 2012).  
ELISA kits were used to measure the levels of cytokines per group.  IL-10, an anti-
inflammatory cytokine and marker of M2 macrophages, was measured and 
demonstrated a significant increase in the ACM+BMP-7 group and a significant 
decrease in the ACM and ACM+BMP-7+Foll group (Figure 3A).  Figure 3B shows 
expression of IL-1ra, another anti-inflammatory cytokine, with also a significant increase 
in the ACM+BMP-7 group. IL-6, TNF- α and MCP-1 are pro-inflammatory cytokines that 
are known to be expressed by M1 macrophages and contribute to the progression of 
inflammatory diseases, were also measured (Weis et al., 2009;Rocher et al., 2012).  
Figures 3C-D show quantitative analysis of expression of the pro-inflammatory 
cytokines with a significant decrease in the ACM+BMP-7 group suggesting that 




Figure 3:  BMP-7 increases anti-inflammatory cytokine expression and decreases pro-
inflammatory cytokine expression.  Histogram (A) shows quantitative analysis of IL-10.  
Histogram (B) shows quantitative analysis of IL-1ra.  Histogram (C) shows quantitative 
analysis of IL-6. Histogram (D) shows quantitative analysis of TNF- α.  Histogram (E) 





BMP-7 Treatment Activates the SMAD1/5/8 Pathway 
When BMP-7 binds to BMPR2 located on the THP-1 cells, the SMAD1/5/8 
pathway gets activated which results in gene expression (Perron and Dodd, 2009;Boon 
et al., 2011).  Western blot analysis was utilized to ascertain the expression of 
SMAD1/5/8 per group.  Figure 4A shows representative western blot bands for 
SMAD1/5/8 and β-actin.  Densitometry analysis of the western blot bands showed that 
expression of SMAD1/5/8 was significantly higher in the ACM+BMP-7 group suggesting 
that BMP-7 is successfully binding the receptor and further confirming that the receptor 




Figure 4:  Treatment with BMP-7 increases activation of SMAD1/5/8 pathway.  
Representative western blot bands (A) are shown of p-SMAD1/5/8 and β-actin.  
Histogram (B) shows analysis of p-SMAD1/5/8.  *p<0.05 vs Control, #p<0.05 vs ACM, 

























































Binding of BMPR2 Activates Non-SMAD Pathway PI3K-Akt-mTOR 
Studies have shown that activation of the BMPR2 can also result in activation of 
non-SMAD related pathways such as the PI3K pathway (Shimizu et al., 2012).  When 
binding occurs, the p85 subunit of PI3K gets activated which allows for downstream 
activation of Akt and mTOR (Weichhart and Saemann, 2008;Weichhart and Saemann, 
2009;Shimizu et al., 2012).  Western blot analysis was used to measure the expression 
levels of each protein.  Figure 5A shows representative western blot bands for p-PI3K 
and total PI3K.  Densitometric analysis of the western blot bands showed significantly 




Figure 5:  Activation of SMAD1/5/8 pathway results in activation of the p85 subunit of 
PI3K.  Representative western blot bands (A) are shown of p-PI3k and total PI3K.  


























































Furthermore, Figure 6A and 6C show representative western blot bands for p-Akt 
and p-PTEN with β-actin.  Densitometric analysis of the p-Akt western blot bands show 
a significant increase in expression of the ACM+BMP-7 group (Figure 6B).  Figure 6D, 
however, shows densitometric analysis of p-PTEN, an inhibitor of Akt, with a significant 
decrease in the ACM+BMP-7 group and a significant increase in the ACM and 
ACM+BMP-7+Foll groups. This suggests that PTEN is significantly inhibiting the PI3K 
pathway.  Figure 7A shows representative western blot bands of p-mTOR and total 
mTOR.  Densitometric analysis of the western blot bands show a significant increase in 
























































































































Figure 6:  Activation of PI3K results in downstream phosphorylation of Akt.  
Representative western blot bands (A) are shown of p-Akt and β-actin.  Histogram (B) 
shows analysis of p-Akt.  Representative western blot bands (C) are shown of p-PTEN 
and β-actin.  Histogram (D) shows analysis of p-PTEN.  *p<0.05 vs Control, #p<0.05 vs 





Figure 7:  Downstream activation of mTOR occurs following phosphorylation of Akt.  
Representative western blot bands (A) are shown of p-mTOR and total mTOR.  
Histogram (B) shows densitometric analysis of the western blot bands for p-mTOR.  

























































CHAPTER 4: DISCUSSION  
Monocyte polarization is an important area of research that plays a significant 
role in disease progression.  During the onset of atherosclerosis, monocytes move to 
the artery and polarize based on the stimuli they receive from the environment (Boon et 
al., 2011;Moore and Tabas, 2011;Rocher et al., 2012).  In the early stages of 
atherosclerosis, monocytes polarize to M2 macrophages, which secrete anti-
inflammatory cytokines to decrease the inflammatory response and prevent further 
injury and also phagocytize the apoptotic cellular debris (Libby et al., 2009;Galkina and 
Ley, 2009;Moore and Tabas, 2011).  Unfortunately, as the atherosclerosis progresses 
and the injury worsens, apoptosis increases and the cellular debris becomes necrotic 
resulting in secretion of pro-inflammatory cytokines, which then induce the infiltrating 
monocytes to polarize to an M1 macrophage cell type (Thorp and Tabas, 2009;Seimon 
and Tabas, 2009).  Being able to control the ratio of M1 to M2 macrophages could 
inhibit the severity of the inflammatory response and allow for injury repair. 
 Studies have shown that monocytes are triggered to polarize based on the 
stimuli they receive such as apoptotic cell death or increased cytokine levels (Voll et al., 
1997;Weigert et al., 2006;Rocher et al., 2012).  In this study, we wanted to mimic the 
inflammatory environment by adding apoptotic conditioned media (ACM) which has 
been published by others and us (Xu et al., 2006;Weis et al., 2009;Rocher et al., 2012).  
Adding this stressed condition induced the THP-1 cells to polarize from monocytes to 
macrophages.  To increase the polarization of monocytes to M2 macrophages BMP-7 
was added to the THP-1.  In this study when the THP-1 cells are treated with BMP-7 
under stressed conditions for 48 hours, we see an increase in M2 macrophage markers 
22 
suggesting that BMP-7 is successfully polarizing the THP-1 cells.  We further confirmed 
that BMPR2 is located on THP-1 cells through double label immunostaining with CD14, 
a monocyte marker (Urbich et al., 2003;Rocher et al., 2012).  In addition, we showed 
that expression of BMPR2 is significantly increased following treatment with BMP-7 
compared to control.  We also showed that BMPR2 is found on M2 macrophages, which 
was demonstrated through the double immunostaining performed on the THP-1 cells 
following treatment, and was seen with the CD14 positive cells, expression was 
significantly increased in the ACM+BMP-7 group compared to control. 
 Cell polarization was demonstrated through multiple methods, the first being 
immunohistochemistry of the various monocyte and macrophage markers.  Following 
48-hour treatment of the THP-1 cells with BMP-7 under stressed conditions; the cell 
smears were stained with anti-CD14, anti-CD206, anti-arginase-1 and anti-iNOS.  The 
CD14 marker confirmed that the THP-1 cells are monocytes and that following 
treatment the percentage of CD14 positive cells decreased.  Seeing that the percentage 
decreased suggested that the cells are polarizing to another cell type.   
CD206 and arginase-1, two markers of M2 macrophages, stainings were next 
performed to see if indeed BMP-7 was successfully polarizing the cells to an M2 
macrophage cell type (Sinha et al., 2005;El et al., 2012).  As shown in the results 
section, the percentage of cells expressing CD206 and arginase-1 was significantly 
increased in the ACM+BMP-7 group and significantly decreased in the ACM and 
ACM+BMP-7+Foll groups.  This suggests that THP-1 cells are polarizing into M2 
macrophages do to treatment with BMP-7.  Furthermore, the decrease of expression of 
CD206 and arginase-1 in the follistatin group demonstrates that inhibition of BMP-7 is 
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occurring and that since expression of M2 macrophage markers decreases when BMP-
7 is inhibited then BMP-7 must play an important role in the M2 macrophage 
polarization.  This is further shown by the iNOS immunostaining performed on the THP-
1 cells.  A significant increase of iNOS expression was shown in the ACM and the 
ACM+BMP-7+Foll groups but a significant decrease in the ACM+BMP-7 group showing 
that BMP-7 treatment induces M2 macrophage polarization and not M1. 
Cell polarization was further demonstrated through ELISA analysis of pro and 
anti-inflammatory cytokine expression for each group.  Levels of pro-inflammatory 
cytokines IL-6, TNF- α and MCP-1 and anti-inflammatory cytokines IL-10 and IL-1ra 
were performed (Libby et al., 2009; Wolfs et al., 2011; El et al., 2012; Rocher et al., 
2012).  The BMP-7 treated group was able to significantly lower levels of these pro-
inflammatory cytokines compared to the ACM group but significantly increase levels of 
IL-10 and IL-1ra.  We show that following treatment with BMP-7, THP-1 cells polarize 
into M2 macrophages.  This data confirms studies done by others and us that BMP-7 
can reduce levels of pro-inflammatory cytokines and be used as a treatment for 
inflammatory diseases such as atherosclerosis (Rocher et al., 2012).   
Understanding the mechanism for how BMP-7 polarizes THP-1 cells was 
previously unknown.  In this study, we show that BMP-7 works through two pathways.  
The first pathway is SMAD1/5/8, a known mechanism for BMP-7 when binding occurs 
through BMPR2 (Boon et al., 2011;Rocher et al., 2012).  Western blot analysis confirms 
that activation of the SMAD1/5/8 pathway occurs in the ACM+BMP-7 group.  
Furthermore, it not only demonstrates that successful binding of BMP-7 occurs but also 
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correlates with the data from Figure 1A regarding the location of the receptor on the cell 
surface, since activation of the SMAD1/5/8 pathway occurs following binding of BMPR2. 
In this study we also show that following binding of BMPR2 with BMP-7, the 
PI3K-Akt-mTOR pathway is also activated.  Studies have shown that this pathway is 
very important to M2 macrophage polarization and its activation is seen as almost a 
requirement for M2 macrophage polarization to occur (Martin et al., 2003;Rauh et al., 
2005;Weichhart and Saemann, 2008).  Inhibition of either PI3K or mTOR, by their 
respective inhibitors results in polarization toward an M1 macrophage type with 
increased pro-inflammatory cytokine expression (Martin et al., 2003; Rauh et al., 2005; 
Weichhart and Saemann, 2009; Araki et al., 2011).  Although studies have shown that 
activation of this pathway can occur through BMPR2, no one has yet to show the 
correlation of this activation with the polarization of M2 macrophages.  In this study, 
through western blot analysis, we show that expression of p-PI3K, p-Akt and p-mTOR is 
significantly increased in the ACM+BMP-7 group.  Conversely, western blot analysis of 
p-PTEN shows that in the ACM and ACM+BMP-7+Foll groups, inhibition of the PI3K 
pathway occurs which correlates with our previous data regarding cell polarization.  The 
groups that had increased expression of the PI3K pathway also had increased 
expression of M2 macrophage markers whereas groups that had decreased expression 
of PI3K had increased expression of M1 macrophage markers.  This data suggests that 
activation of the PI3K pathway is necessary for M2 macrophage polarization. 
In conclusion, this study demonstrates that treatment with BMP-7 polarizes THP-
1 cells into M2 macrophages.  We showed that THP-1 cells treated with BMP-7 had 
increased expression of M2 macrophage markers as well as increased levels of anti-
25 
inflammatory cytokines.  Furthermore, our data suggests that polarization occurs 
through activation of the PI3K-Akt-mTOR pathway following binding of BMPR2. 
Acknowledgments 
I sincerely thank Bin Bin Yan for taking the confocal image and Reetu Singla for 
helping me with the in vitro model. 
  
26 
LIST OF REFERENCES 
Amthor H, Christ B, Rashid-Doubell F, Kemp CF, Lang E and Patel K (2002) Follistatin 
Regulates Bone Morphogenetic Protein-7 (BMP-7) Activity to Stimulate 
Embryonic Muscle Growth. Dev Biol 243:115-127. 
Araki K, Ellebedy AH and Ahmed R (2011) TOR in the Immune System. Curr Opin Cell 
Biol 23:707-715. 
Beck SE and Carethers JM (2007) BMP Suppresses PTEN Expression Via RAS/ERK 
Signaling. Cancer Biol Ther 6:1313-1317. 
Boon MR, van der HG, van der PG, Tamsma JT, Smit JW and Rensen PC (2011) Bone 
Morphogenetic Protein 7: a Broad-Spectrum Growth Factor With Multiple Target 
Therapeutic Potency. Cytokine Growth Factor Rev 22:221-229. 
El HK, Mahmood DF, Couchie D, Jguirim-Souissi I, Genze F, Diderot V, Syrovets T, 
Lunov O, Simmet T and Rouis M (2012) Thioredoxin-1 Promotes Anti-
Inflammatory Macrophages of the M2 Phenotype and Antagonizes 
Atherosclerosis. Arterioscler Thromb Vasc Biol 32:1445-1452. 
Galkina E and Ley K (2009) Immune and Inflammatory Mechanisms of Atherosclerosis 
(*). Annu Rev Immunol 27:165-197. 
Libby P, Ridker PM and Hansson GK (2009) Inflammation in Atherosclerosis: From 
Pathophysiology to Practice. J Am Coll Cardiol 54:2129-2138. 
Martin M, Schifferle RE, Cuesta N, Vogel SN, Katz J and Michalek SM (2003) Role of 
the Phosphatidylinositol 3 Kinase-Akt Pathway in the Regulation of IL-10 and IL-
12 by Porphyromonas Gingivalis Lipopolysaccharide. J Immunol 171:717-725. 
27 
Moore KJ and Tabas I (2011) Macrophages in the Pathogenesis of Atherosclerosis. Cell 
145:341-355. 
Perron JC and Dodd J (2009) ActRIIA and BMPRII Type II BMP Receptor Subunits 
Selectively Required for Smad4-Independent BMP7-Evoked Chemotaxis. PLoS 
One 4:e8198. 
Rauh MJ, Ho V, Pereira C, Sham A, Sly LM, Lam V, Huxham L, Minchinton AI, Mui A 
and Krystal G (2005) SHIP Represses the Generation of Alternatively Activated 
Macrophages. Immunity 23:361-374. 
Rocher C, Singla R, Singal PK, Parthasarathy S and Singla DK (2012) Bone 
Morphogenetic Protein 7 Polarizes THP-1 Cells into M2 Macrophages. Can J 
Physiol Pharmacol 90:947-951. 
Seimon T and Tabas I (2009) Mechanisms and Consequences of Macrophage 
Apoptosis in Atherosclerosis. J Lipid Res 50 Suppl:S382-S387. 
Shimizu T, Kayamori T, Murayama C and Miyamoto A (2012) Bone Morphogenetic 
Protein (BMP)-4 and BMP-7 Suppress Granulosa Cell Apoptosis Via Different 
Pathways: BMP-4 Via PI3K/PDK-1/Akt and BMP-7 Via PI3K/PDK-1/PKC. 
Biochem Biophys Res Commun 417:869-873. 
Singla DK and McDonald DE (2007) Factors Released From Embryonic Stem Cells 
Inhibit Apoptosis of H9c2 Cells. Am J Physiol Heart Circ Physiol 293:H1590-
H1595. 
Sinha P, Clements VK and Ostrand-Rosenberg S (2005) Interleukin-13-Regulated M2 
Macrophages in Combination With Myeloid Suppressor Cells Block Immune 
Surveillance Against Metastasis. Cancer Res 65:11743-11751. 
28 
Thorp E and Tabas I (2009) Mechanisms and Consequences of Efferocytosis in 
Advanced Atherosclerosis. J Leukoc Biol 86:1089-1095. 
Urbich C, Heeschen C, Aicher A, Dernbach E, Zeiher AM and Dimmeler S (2003) 
Relevance of Monocytic Features for Neovascularization Capacity of Circulating 
Endothelial Progenitor Cells. Circulation 108:2511-2516. 
Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR and Girkontaite I (1997) 
Immunosuppressive Effects of Apoptotic Cells. Nature 390:350-351. 
Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S 
and Hruska KA (2003) Bone Morphogenic Protein-7 (BMP-7), a Novel Therapy 
for Diabetic Nephropathy. Kidney Int 63:2037-2049. 
Weichhart T and Saemann MD (2008) The PI3K/Akt/MTOR Pathway in Innate Immune 
Cells: Emerging Therapeutic Applications. Ann Rheum Dis 67 Suppl 3:iii70-iii74. 
Weichhart T and Saemann MD (2009) The Multiple Facets of MTOR in Immunity. 
Trends Immunol 30:218-226. 
Weigert A, Johann AM, von KA, Schmidt H, Geisslinger G and Brune B (2006) 
Apoptotic Cells Promote Macrophage Survival by Releasing the Antiapoptotic 
Mediator Sphingosine-1-Phosphate. Blood 108:1635-1642. 
Weis N, Weigert A, von KA and Brune B (2009) Heme Oxygenase-1 Contributes to an 
Alternative Macrophage Activation Profile Induced by Apoptotic Cell 
Supernatants. Mol Biol Cell 20:1280-1288. 
Wolfs IM, Donners MM and de Winther MP (2011) Differentiation Factors and Cytokines 
in the Atherosclerotic Plaque Micro-Environment As a Trigger for Macrophage 
Polarisation. Thromb Haemost 106:763-771. 
29 
Woollard KJ and Geissmann F (2010) Monocytes in Atherosclerosis: Subsets and 
Functions. Nat Rev Cardiol 7:77-86. 
Xu W, Roos A, Schlagwein N, Woltman AM, Daha MR and van KC (2006) IL-10-
Producing Macrophages Preferentially Clear Early Apoptotic Cells. Blood 
107:4930-4937. 
 
 
